The transcription factor T-bet has been associated with increased susceptibility to systemic and organ-specific autoimmunity, but the mechanism by which T-bet expression promotes neuroinflammation remains unknown. In this study, we demonstrate a cardinal role of T-bet-dependent NKp46 + innate lymphoid cells (ILCs) in the initiation of CD4 + T H 17-mediated neuroinflammation. Loss of T-bet specifically in NKp46 + ILCs profoundly impaired the ability of myelin-reactive T H 17 cells to invade central nervous system (CNS) tissue and protected the mice from autoimmunity. T-bet-dependent NKp46 + ILCs localized in the meninges and acted as chief coordinators of meningeal inflammation by inducing the expression of proinflammatory cytokines, chemokines and matrix metalloproteinases, which together facilitated T cell entry into CNS parenchyma. Our findings uncover a detrimental role of T-bet-dependent NKp46 + ILCs in the development of CNS autoimmune disease.
Multiple sclerosis is the most common demyelinating disease of the CNS and is a leading cause of neurological disability in young adults 1 . Considerable progress has been made in understanding immunological events that lead to the development of multiple sclerosis, through use of the experimental autoimmune encephalomyelitis (EAE) model of inflammatory demyelination. Genetic targeting of the cytokines IL-12 and IL-23, which are necessary for the development and terminal differentiation of interferon-γ (IFN-γ)-producing CD4 + T helper 1 (T H 1) and IL-17-producing T helper 17 (T H 17) cells, respectively, has revealed that T H 17 cells, and not T H 1 cells, are essential for the development of EAE [2] [3] [4] [5] . After peripheral activation, pathogenic T H 17 cells migrate to the CNS and accumulate in the perivascular spaces and meninges. Here, autoantigen-driven T cell reactivation by CNS-resident antigen-presenting cells (APCs) is a prerequisite for the initiation of the inflammatory cascade by T H 17 cells 6 . However, the underlying immunological factors that promote the migration of immune cells from the site of reactivation into CNS parenchyma are still not well understood.
The T-box transcription factor T-bet is critical for the development of immunopathology during EAE 7, 8 . T-bet is encoded by Tbx21 and is expressed in multiple immune-cell lineages of the immune system 9 . As a critical regulator of the type 1 inflammatory response, T-bet is required for the activation of host immunodefense mechanisms against infectious microorganisms 10 . However, excessive T-bet-regulated immune responses have been linked to the pathogenesis of immunologically mediated disorders 10 . Although T-bet was initially defined as the master regulator of the T H 1 differentiation program, accumulating data indicate that T-bet is essential for the pathogenicity of T H 17 cells in EAE [11] [12] [13] . Its expression in T H 17 cells is induced in response to IL-12 or IL-23 signaling 11, 12, 14 . T-bet promotes the functional plasticity and amplifies the inflammatory potential of T H 17 cells by upregulating endogenous production of the cytokine TGF-β3 (refs. 11,12) . Whether T-bet expression in immune cells other than T H 17 cells contributes to the pathogenesis of EAE is presently unknown.
Here, we demonstrate that T-bet expression in myelin-reactive T H 17 cells is necessary but not sufficient for the development of EAE. We established a highly selective requirement for T-bet-dependent NKp46 + ILCs in the initiation of T H 17-mediated neuroinflammation. Specifically, we found that T-bet-dependent NKp46 + ILCs control the CNS parenchymal infiltration of myelin-reactive T H 17 cells by generating a proinflammatory-cytokine environment in the meninges that is necessary for the reactivation and maintenance of IL-17A-producing CD4 + T cells in the CNS. Our findings demonstrate a pathogenic role of NKp46 + ILCs in neuroinflammation and identify NKp46 + ILCs as a potential target for the treatment of inflammatory CNS disorders.
RESULTS

T-bet expression in T cells is insufficient to cause EAE
To better understand the role of T-bet in the pathogenesis of autoimmune diseases, we first sought to determine whether T-bet expression 1 1 1 8 VOLUME 18 NUMBER 10 OCTOBER 2017 nature immunology A r t i c l e s in cells of hematopoietic origin is required for the development of organ-specific immunopathology. To address this question, we generated conditionally T-bet-deficient mice (Tbx21 f/f Vav1-Cre + ) in which Tbx21 was deleted in hematopoietic cells. We tested the effects of hematopoietic-system-specific deletion of T-bet on susceptibility to EAE by immunizing Tbx21 f/f Vav1-Cre + mice and Tbx21 f/f controls with a CNS-derived antigen, myelin oligodendrocyte glycoprotein peptide, amino acids 35-55 (MOG ). Hematopoietic ablation of Tbx21 gene expression significantly attenuated EAE, a phenotype mimicking germline T-bet deficiency (Tbx21 −/− ), thus suggesting that the pathogenic role of T-bet mapped to the cells of the hematopoietic system (Fig. 1a,b) .
We therefore sought to determine the immune-cell lineages in which T-bet expression is required to drive neuroinflammation. To this end, MOG peptide-reactive T-bet-deficient (2D2 Tbx21 −/− ) and T-bet-sufficient (2D2 wild-type) CD4 + T cells were activated under T H 17-polarizing conditions and adoptively transferred into either T-bet-deficient (Tbx21 −/− ) or wild-type hosts. 2D2 Tbx21 −/− T H 17 cells did not induce EAE in either Tbx21 −/− or wild-type recipients (Fig. 1c) , thus confirming the requirement for T cell-intrinsic expression of T-bet in the pathology of EAE. 2D2 wild-type T H 17 cells, although fully capable of inducing disease in wild-type recipients, were not pathogenic in Tbx21 −/− recipients, thus demonstrating that T cell-intrinsic expression of T-bet cells is necessary but not sufficient to cause EAE (Fig. 1c) . Furthermore, infiltration of cells into the CNS parenchyma was substantially lower in Tbx21 −/− recipients than in wild-type controls (Fig. 1d) , a finding further confirmed by histological analysis (Fig. 1e) . These results revealed that T-bet expression in immune cells other than myelin-reactive CD4 + T H 17 cells is additionally required for the pathogenesis of autoimmune CNS disease.
Peripheral licensing of CD4 + T H 17 cells in Tbx21 −/− hosts Adoptively transferred myelin-reactive CD4 + T cells acquire the capacity to enter the CNS after effective activation within the lungs 15 . We asked whether peripheral licensing of adoptively transferred 2D2 wild-type T H 17 cells occurred normally in the lungs of Tbx21 −/− recipients. Adoptively transferred 2D2 wild-type T H 17 cells egressed and proliferated normally in the spleen and lungs of both Tbx21 −/− and wild-type recipients (Fig. 2a,b) . In agreement with findings from previous reports 15, 16 , myelin-reactive CD4 + T cells transitioned to a migratory mode in the lung through upregulation of the expression of the integrins α 4 (VLA-4 subunit) and α L (LFA-1 subunit) and the chemokine receptors CXCR4 and CCR6. Notably, the expression of these adhesion molecules and chemokine receptors on 2D2 wild-type T H 17 cells was not affected by T-bet deficiency in the recipient mice (Fig. 2c) . Furthermore, 2D2 CD4 + T cells isolated from the spleens and lungs of Tbx21 −/− and wild-type recipients had similar percentages of cytokine-producing cells (Fig. 2d) . Collectively, these data demonstrated that T-bet is not required for the licensing of 2D2 wildtype T H 17 cells in the periphery.
We next sought to determine whether T-bet deficiency in recipient mice affected the effector function of 2D2 wild-type T H 17 in the CNS. In addition to recovering fewer 2D2 CD4 + T cells (Fig. 1c) , we detected a substantially lower frequency of IL-17A + IFN-γ − and IL-17A + IFN-γ + 2D2 CD4 + T cells in the CNS in Tbx21 −/− recipients compared with wild-type controls (Fig. 2e) . The adoptive transfer experiments with T-bet-sufficient 2D2 T H 17 cells demonstrated that T-bet expression in a non-T cell compartment controls the parenchymal infiltration and the effector function of autoreactive CD4 + T H 17 cells in the CNS.
T-bet-expressing cells in the CNS during EAE
We next aimed to identify T-bet-expressing cells that are necessary for the optimal activation of CD4 + T H 17 cells in the CNS during EAE, by using previously established T-bet-ZsGreen reporter mice 17 . After EAE induction, numerous ZsGreen + cells were detected in the meninges and the central canal, and throughout the spinal-cord parenchyma ( Fig. 3a) . Approximately 50% of CNS-infiltrating CD45 + leukocytes expressed T-bet at the peak of disease (Fig. 3b) . We found that most T cells and NK1.1 + cells, and a fraction of dendritic cells (DCs) expressed T-bet during EAE (Fig. 3c) . The numbers of T-betexpressing T cells and DCs increased in the CNS from the onset to the peak of disease. In contrast, T-bet-expressing NK1.1 + cells were detected in the CNS at early stages of disease, and their numbers remained unchanged throughout the course of disease (Fig. 3d) . Therefore, we proceeded to investigate the effects of T-bet deficiency in T cells, DCs and NK1.1 + cells on the effector function of 2D2 wildtype T H 17 cells and their ability to induce neuropathology.
Endogenous T-bet + T cells and DCs do not affect EAE Analysis of cell infiltration during EAE revealed that most of the CNS-infiltrating CD4 + T cells were adoptively transferred 2D2 CD4 + T cells expressing the transgenic T cell receptor chain V β 11, whereas approximately 15% of the CNS-infiltrating CD4 + T cells were endogenous (host-derived) CD4 + T cells (Supplementary Fig. 1a ). Fig. 1a) . In contrast to Tbx21 f/f controls, endogenous CD4 + T cells in the CNS in Tbx21 f/f CD4-Cre + contained a higher percentage of IL-17A + IFN-γ − cells and a significantly lower percentage of IL-17A − IFN-γ + cells ( Supplementary Fig. 1b) ;
nevertheless, this alteration in the cytokine profile of endogenous CD4 + T cells had no effects on the cytokine production or pathogenicity of adoptively transferred 2D2 wild-type T H 17 cells (Supplementary Fig. 1c,d ).
Major histocompatibility complex class II (MHCII)-restricted antigen presentation by meningeal and perivascular CD11c + DCs and macrophages is required for the reactivation of primed myelin-reactive T cells, thus leading to CNS invasion and subsequent clinical disease development 6, [18] [19] [20] . Because 2D2 wild-type T H 17 cells showed suboptimal cytokine production in the CNS in Tbx21 −/− mice, we tested the importance of T-bet expression in DCs by transferring 2D2 wild-type T H 17 cells into Tbx21 f/f CD11c-Cre + recipients, which lacked T-bet expression in DCs, and into Tbx21 f/f controls. We found that DCspecific loss of T-bet had no effect on the pathogenicity of adoptively transferred 2D2 wild-type T H 17 cells in the CNS ( Supplementary  Fig. 2a,b) . Collectively, these results showed that the infiltration and optimal effector function of adoptively transferred 2D2 wild-type T H 17 cells in the CNS is not dependent on T-bet expression in endogenous (host-derived) T cells, NK T cells and DCs. Fig. 3 ). Tbx21 −/− recipients depleted of NK1.1 + cells remained resistant to EAE induction by 2D2 wild-type T H 17 cells (Fig. 4a) . By contrast, wild-type mice treated with anti-NK1.1, compared with controls, showed a significantly attenuated EAE disease T-bet is a key factor in the terminal maturation and homeostasis of NK and V α 14i NK T cells and in lineage specification of ILC1 and NKp46 + ILC3 (refs. 21-27) . To evaluate the requirement of T-bet in NK cells, ILC1 and the NKp46 + subset of ILC3, we generated mice with genetic deletion of T-bet in all three ILC subsets by crossing Tbx21 f/f mice to NKp46-Cre + (also known as Ncr1-Cre + ) transgenic mice. After the adoptive transfer of 2D2 wild-type T H 17 cells, mice with the NKp46-specific ablation of T-bet (Tbx21 f/f NKp46-Cre + ) exhibited significantly lower mean clinical scores and percentage disease incidence than those in controls (Fig. 4c,d) . However, the maximum EAE disease score for symptomatic Tbx21 f/f NKp46-Cre + mice was not significantly different from that for Tbx21 f/f controls (Fig. 4d) . These results demonstrated that the primary function of T-bet-dependent NKp46 + ILCs is to control the onset of T H 17-mediated neuroinflammation, but after the disease is induced, these cells are not required for the effector stage of neuroinflammation.
Localization of T-bet-dependent NKp46 + ILCs during EAE
The meninges of the CNS constitute an additional licensing checkpoint in which autoantigen-driven T cell reactivation by CNS-resident APCs is a prerequisite for CNS parenchymal infiltration and subsequent demyelinating pathology 6 . Because T-bet-dependent NKp46 + ILCs affected the onset of T H 17-mediated neuroinflammation, we hypothesized that the NKp46 + ILCs might be strategically positioned in the meninges, where they mediate the process of 2D2 wild-type T H 17 cell reactivation. To assess this possibility, we used a combination of high-resolution confocal microscopy and histocytometry to directly investigate the localization of NKp46 + ILCs, 2D2 CD4 + T H 17 cells and MHCII-expressing APCs (Fig. 5a,b) . The most prominent feature of the immune response in the meninges was the formation of discrete cellular clusters containing large numbers of NKp46 + ILCs tightly juxtaposed with both MHCII + APCs and 2D2 CD4 + T cells. The NKp46 + ILC-T cell-APC clusters were detected in the spinalcord meninges even before the onset of symptoms (score 0, Fig. 5a ), thus indicating that they may indicate the precise anatomical location of 2D2 CD4 + T cell reactivation. Preferential localization of NKp46 + ILCs within the dense clusters of MHCII + APCs and 2D2 CD4 + T cells was additionally confirmed by histocytometry (Fig. 5b) . Collectively, these observations demonstrated that NKp46 + ILCs are localized in the meninges, where they may foster 2D2 CD4 + T cell reactivation by influencing the function of APCs and/or autoreactive CD4 + T cells.
Pathogenic function of T-bet maps to ILC1/NKp46 + ILC3
To investigate the importance of NKp46 + ILCs in the pathophysiology of CD4 + T H 17-mediated neuroinflammation, we used multiparameter flow cytometry to identify ILC subsets and analyze their function in the meninges in Tbx21 f/f and Tbx21 f/f NKp46-Cre + recipients. In comparison with those in control mice, the meninges in Tbx21 f/f NKp46-Cre + mice exhibited a profound deficiency in NKp46 + ILCs (Fig. 6a,b) . We observed significantly lower numbers of conventional NK cells and ILC1s but a comparable number of NKp46 + ILC3s in Tbx21 f/f NKp46-Cre + recipients compared with Tbx21 f/f recipients (Fig. 6c) . T-bet-dependent NKp46 + ILCs predominantly produced IFN-γ, and very few IFN-γ-producing NK cells and ILC1 were detected in the meninges in Tbx21 f/f NKp46-Cre + mice (Fig. 6a,c) . Additionally, a twofold decrease in the number of IFN-γ-producing NKp46 + ILC3s was detected in the meninges in Tbx21 f/f NKp46-Cre + mice compared with Tbx21 f/f mice (Fig. 6c) [28] [29] [30] [31] [32] . To clarify this long-standing issue regarding the relevance of NK cells to EAE, we generated NK cell-deficient Eomes f/f NKp46-Cre + mice 33 ( Supplementary Fig. 4a,b) . Passive transfer of 2D2 wild-type T H 17 cells induced EAE of equal severity in NK cell-sufficient and NK celldeficient mice (Fig. 6d,e) , thus demonstrating that NK cells do not have a major role in T H 17-induced neuroinflammation. Therefore, the pathogenic role of T-bet within NKp46 + ILCs maps to ILC1 and/or the NKp46 + subset of ILC3. (Fig. 7a) . By contrast, loss of T-bet expression in NKp46 + ILCs resulted in significantly decreased expression of p35, p19, Il1b, Il6, Tnf, Lta, Il17a and Ifng, thus demonstrating that T-bet-dependent NKp46 + ILCs directly or indirectly shape the inflammatory microenvironment in the meninges during T H 17-mediated neuroinflammation (Fig. 7a) . We hypothesized that ILC-mediated cytokine changes in the meninges might be an important factor controlling parenchymal infiltration of immune cells. We found that the meningeal accumulation of 2D2 wild-type T H 17 cells was not significantly different between Tbx21 f/f and Tbx21 f/f NKp46-Cre + mice. In contrast, the parenchymal infiltration of 2D2 wild-type T H 17 cells was significantly lower in the Tbx21 f/f NKp46-Cre + mice (Fig. 7b) , a result further confirmed by histological analysis (Fig. 7c) . Integrins α 4 and α L are required for the firm adhesion and extravasation of encephalitogenic T cells, whereas CCR6 and its ligand, CCL20, regulate the entry of T H 17 cells into the CNS [35] [36] [37] . We found that the CNS-infiltrating 2D2 CD4 + T cells expressed comparable amounts of both integrins and CCR6 in Tbx21 f/f and Tbx21 f/f NKp46-Cre + mice (Fig. 7d) , thus indicating that the lack of migration into CNS parenchyma was not due to a T cellintrinsic defect and that meningeal T-bet-dependent NKp46 + ILCs may regulate the parenchymal infiltration of 2D2 CD4 + T cells.
T-bet-dependent NKp46 + ILCs may affect 2D2 CD4 + T H 17 cell parenchymal infiltration indirectly by influencing the capacity of meningeal APCs to reactivate 2D2 CD4 + T H 17 cells in situ. Activation of APCs, as measured by upregulation of MHCII, the co-stimulatory molecule CD80 and the adhesion molecule ICAM-1, is dependent on IFN-γ. Like Tbx21 f/f NKp46-Cre + mice, Ifng −/− recipient mice were protected from T H 17-mediated neuroinflammation in the passive EAE model 38 (Supplementary Fig. 5a ). Ifng −/− mice showed a substantial defect in the recruitment of 2D2 CD4 + T cells, myeloid DCs, inflammatory monocytes and neutrophils to the spinal-cord meninges after Fig. 5b,c) . Additionally, resident APCs (CD206 + perivascular macrophages) did not upregulate MHCII, CD80 and ICAM-1, whereas myeloid DCs showed significantly lower expression of CD80 and ICAM-1 in the meninges in Ifng −/− mice compared with wild-type mice (Supplementary Fig. 5d ; gating strategy in Supplementary  Fig. 6 ). Collectively, these data established that IFN-γ is critical in driving the recruitment and activation of meningeal APCs. Next, we asked whether IFN-γ expression by NKp46 + ILCs was essential for optimal activation of meningeal APCs and consequently for optimal reactivation of 2D2 CD4 + T cells in vivo. In contrast to Ifng −/− mice, Tbx21 f/f NKp46-Cre + mice showed normal recruitment and activation of meningeal APCs after the adoptive transfer of 2D2 wild-type T H 17 cells (Supplementary Fig. 7a,b) , thus demonstrating that the expression of IFN-γ by NKp46 + ILCs is not required for the recruitment or activation of meningeal APCs and that other cellular sources of IFN-γ can compensate for the lack of an innate source of IFN-γ. Under neuroinflammatory conditions, the gradient of chemokines produced and induced by meningeal immune cells promotes leukocyte transmigration across the blood-brain barrier into the CNS parenchyma 39 . The expression of matrix metalloproteinases (MMPs) by both resident and immune cells strongly enhances this transmigration process by breaking down the glia limitans as well as by modulating the activity of chemokines at the parenchymal border 40 . Because the expression of MMPs and chemokines is regulated by proinflammatory cytokines, we hypothesized that T-bet-dependent NKp46 + ILCs facilitate 2D2 CD4 + T H 17 cell parenchymal infiltration indirectly by inducing the expression of MMPs and chemokines in the meninges and parenchyma, respectively. To test this hypothesis, we used quantitative RT-PCR to examine MMP and chemokine expression in the meninges and parenchyma in Tbx21 f/f and Tbx21 f/f NKp46-Cre + mice after adoptive transfer of 2D2 wild-type T H 17 cells. Loss of T-bet expression in NKp46 + ILCs abrogated the mRNA expression of major MMPs implicated in EAE, such as MMP2, MMP3, MMP9, MMP13, MMP14 and MMP19 in the meninges (Fig. 7e) . Additionally, significantly fewer chemokine mRNAs (Ccl2, Ccl3, Ccl4, Ccl5, Ccl20, Cxcl9 and Cxcl1) were measured in the parenchyma in Tbx21 f/f NKp46-Cre + mice compared with Tbx21 f/f controls (Fig. 7f) , thus indicating that an optimal chemokine gradient was not established in the parenchyma in Tbx21 f/f NKp46-Cre + mice. Although transferred 2D2 wild-type T H 17 cells expressed comparable amounts of CCR6 (Fig. 7d) maintenance of T H 17 responses was affected in the CNS in Tbx21 f/f NKp46-Cre + mice. We observed a decrease in the frequency of IL-17A + IFN-γ − and an increase in the frequency of IL-17A − IFN-γ + 2D2 CD4 + T cells both in the meninges and parenchyma in Tbx21 f/f NKp46-Cre + recipients compared with Tbx21 f/f controls (Fig. 8a,b) . We additionally detected significantly fewer Il17a transcripts in total CNS extracts from Tbx21 f/f NKp46-Cre + mice compared with Tbx21 f/f controls, thus confirming lower IL-17A production in the former group (Fig. 8c) . These data demonstrated that the loss of Tbet expression in NKp46 + ILCs created a cytokine microenvironment in the meninges that favored the loss of IL-17A-single-producing (IL-17A + IFN-γ − ) 2D2 CD4 + T cells and promoted the differentiation of IFN-γ-single-producing (IL-17A − IFN-γ + ) 2D2 CD4 + T cells. Interestingly, we detected a higher frequency of 2D2 CD4 + T cells producing the growth factor GM-CSF in the meninges and parenchyma in Tbx21 f/f and Tbx21 f/f NKp46-Cre + mice ( Supplementary  Fig. 8 ). Although T cell-derived GM-CSF is required for EAE 44, 45 , it is not sufficient to drive neuroinflammation in Tbx21 f/f NKp46-Cre + mice. Importantly, the extent of myelin destruction and the frequency of apoptotic (TUNEL + ) cells was significantly lower in the spinal cords of Tbx21 f/f NKp46-Cre + mice compared with Tbx21 f/f controls (Fig. 8d,e) , thus indicating that NKp46-lineage specific deletion of T-bet significantly decreased the extent of immune-mediated damage driven by autoreactive CD4 + T H 17 cells. Collectively, these results demonstrated that T-bet-dependent NKp46 + ILCs are required for optimal reactivation, parenchymal invasion and maintenance of myelin-reactive CD4 + T H 17 cells in the CNS tissue.
A r t i c l e s the adoptive transfer of 2D2 wild-type T H 17 cells (Supplementary
DISCUSSION
By using a reductionist in vivo approach, we demonstrated a previously unappreciated requirement for T-bet-dependent NKp46 + ILCs in the pathogenesis of T H 17-driven neuroinflammation. EAE is a neuroinflammatory disease initiated by tissue-invading leukocytes 34 . We found that myelin-reactive, pathogenic CD4 + T H 17 cells invaded and triggered extensive lesions throughout the CNS tissue in immunocompetent hosts, whereas they were absent from the CNS parenchyma in T-bet-deficient hosts. Similarly, adoptive transfer of 2D2 wild-type T H 17 into mice depleted of NK1.1 + cells or into mice with NKp46-lineage specific deletion of T-bet significantly decreased the disease incidence, thus underscoring the importance of NK1.1 + NKp46 + ILCs in the pathology of T H 17-mediated neuroinflammation. This group of innate lymphocytes includes NK cells, ILC1 and the NKp46 + subset of ILC3s 23, 24 . All three subsets of NKp46 + ILCs were readily detected in the meninges in wild-type mice during EAE, thus suggesting that these innate immune cells may have a local effect on tissue-specific immune responses in the CNS. T-bet expression affects many aspects of NK cell homeostasis and function 22, 27, 46, 47 ; hence, Tbx21 −/− and Tbx21 f/f NKp46-Cre + mice may be protected from T H 17-mediated disease because of peripheral NK cell deficiency. However, NK cell-deficient mice developed Our findings also prompt the question of how T-bet-dependent NKp46 + ILCs control the onset of T H 17 cell-mediated neuroinflammation. The pathology of EAE is triggered by the immune-cell invasion of the CNS parenchyma, in a highly regulated process. We believe that T-bet-dependent NKp46 + ILCs create a microenvironment in the meninges that facilitates T cell migration across the parenchymal border, primarily through the induction of proinflammatory cytokines (IL-1β, IL-6, TNF-α, LT-α and IL-23), which then stimulate the expression of MMPs and chemokines. A recent study has shown that the abundance of chemokines and the expression and activity of MMPs are enhanced by encephalitogenic CD4 + T H 17 cells, which produce high levels of IL-17A and TNF, and low levels of IFN-γ (ref. 40) . We observed that the microenvironment in the meninges in Tbx21 f/f NKp46-Cre + skewed the cytokine production by 2D2 CD4 + T cells from IL-17A to IFN-γ, thus indicating that the expression of chemokines and MMPs might be adversely affected by this shift in cytokine production. In agreement with that hypothesis, we found a significant decrease in the levels of chemokines and MMPs in the meninges in Tbx21 f/f NKp46-Cre + mice. Our findings also highlight the developmental instability of CD4 + T H 17 cells, which require constant exposure to T H 17-inducing cytokines to maintain their T H 17-ness.
In summary, we propose that the primary function of T-betdependent NKp46 + ILCs is to promote parenchymal infiltration of myelin-reactive CD4 + T cells and to maintain the functional stability of the T H 17 cells by coordinating appropriate inflammatory responses in the meninges. Additionally, we found that NKp46-lineage-specific deletion of T-bet was sufficient to significantly limit the extent of immune-mediated damage driven by autoreactive CD4 + T H 17 cells. New treatments for neuroinflammation should be designed to selectively limit responses of T-bet-dependent NKp46 + ILCs in the CNS.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
Mice. C57BL/6 (WT), Tbx21 −/− , Eomes f/f , 2D2 TCR-transgenic, Vav1-Cre + , CD4-Cre + , CD11c-Cre + and R26R-YFP mice were purchased from the Jackson Laboratory. Mutant strains were as previously described: NKp46-Cre + (ref. 48), Tbet-ZsGreen reporter 17 , Tbx21 f/f (ref. 49) and Actin-OFP 50 . Male and female mice were used between 7 and 12 weeks of age. Animal experiments were approved by the NCI Institute Animal Care and Use Committee. All mice were maintained in accordance with US National Institutes of Health guidelines.
In vitro differentiation of 2D2 T H 17 cells for adoptive transfer. Naive 2D2 TCR-transgenic CD4 + T cells from the spleen and lymph nodes of 2D2 wildtype or 2D2 Tbx21 −/− mice were electronically sorted (CD4 + V β 11 + CD62L hi ) and activated under T H 17-polarizing conditions, in the presence of irradiated wild-type splenocytes at a 5:1 ratio, with the following: anti-CD3 (2.5 µg/ml) (145-2C11, BioXCell), anti-IL-4 (20 µg/ml) (11B11, BioXCell), anti-IFN-γ (20 µg/ml) (XMG1.2, BioXCell), mIL-6 (30 ng/ml) (Miltenyi Biotec) and hTGF-β1 (3 ng/ml) (Miltenyi Biotec). After 60 h of activation, mIL-23 (10 ng/ml; R&D Systems) was added. On day 5 of culture, cells were reactivated on plates precoated with 2 µg/ml of anti-CD3 and anti-CD28 (PV1, BioXCell) for an additional 48 h, before adoptive transfer.
Active and passive induction of EAE and disease analysis. Active EAE was induced by immunization with the MOG peptide, amino acids 35-55 (MEVGWYRSPFSRVVHLYRNGK). 100 µg MOG peptide was emulsified in complete Freund's adjuvant supplemented with Mycobacterium tuberculosis extract H37Ra (Difco), then injected subcutaneously. Mice received 150 ng pertussis toxin (List Biological Laboratories) intraperitoneally on days 0 and 2. Passive-transfer EAE was induced by injection of 2D2 T H 17-polarized cells (as described above) intravenously into recipient mice at 5 × 10 6 to 7.5 × 10 6 cells/mouse. For NK-depletion experiments, 0.5 mg/dose of purified anti-NK1.1 (clone PK136, BioXCell) was injected intravenously into mice on days −5, −3 and −1 before 2D2 adoptive transfer, and additionally every 3 d from day 1 after 2D2 transfer. Classical EAE symptoms were scored daily according to standard criteria: 0, asymptomatic; 1, flaccid tail; 2, hind-limb weakness and impaired righting ability; 3, hind-limb paralysis; 4, front-and hind-limb paralysis; 5, moribund or death.
Isolation of CNS parenchymal and meningeal cells. For isolation of CNSinfiltrating cells for flow cytometry, brain and spinal-cord tissues were minced and digested with 2.5 mg/ml collagenase D (Roche) and 1 mg/ml DNase I (Roche) for 30 min at 37 °C. Tissues were mechanically disrupted with a gentleMACS Dissociator (Miltenyi), filtered through 70-µm mesh strainers and centrifuged through a Percoll density gradient (38% and 70%). Mononuclear cells in interphase were removed, washed and resuspended in culture medium for analysis by flow cytometry. For isolation of spinal-cord meningeal cells, mice were transcardially perfused with PBS, and the meninges were extracted from the spinal column after removal of the spinal-cord parenchyma. Meninges were digested with 2.5 mg/ml collagenase D and 0.1 mg/ml DNase I for 30 min at 37 °C, then filtered through 70-µm mesh strainers to generate single-cell suspensions.
